Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACYCLOVIR - TAB 400MG | 400MG | TABLET | Resolved | 2017-03-10 | 2018-01-31 | 18 |
| APO-ACYCLOVIR - TAB 400MG | 400MG | TABLET | Resolved | 2019-07-17 | 2019-08-30 | 89570 |
| APO-ACYCLOVIR - TAB 400MG | 400MG | TABLET | Resolved | 2021-09-17 | 2021-09-27 | 145818 |
| APO-ACYCLOVIR - TAB 400MG | 400MG | TABLET | Resolved | 2018-03-05 | 2018-05-24 | 41838 |
| APO-ACYCLOVIR - TAB 400MG | 400MG | TABLET | Resolved | 2020-06-17 | 2020-07-28 | 118040 |
| APO-ACYCLOVIR - TAB 400MG | 400MG | TABLET | Resolved | 2021-06-25 | 2021-07-26 | 141515 |
| APO-ACYCLOVIR - TAB 800MG | 800MG | TABLET | Resolved | 2017-03-10 | 2017-04-21 | 21 |
| APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Resolved | 2021-11-26 | 2021-12-23 | 150052 |
| APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Resolved | 2020-01-08 | 2020-02-19 | 102523 |
| APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Resolved | 2020-07-23 | 2020-09-01 | 120964 |
| APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Actual shortage | 2024-12-19 | 2025-05-01 | 246067 |
| APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Actual shortage | 2025-03-13 | 2025-05-01 | 252560 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2021-11-22 | 2021-12-01 | 149699 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2023-09-07 | 2023-10-20 | 203837 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2022-07-11 | 2022-08-11 | 164370 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2017-06-19 | 2017-09-03 | 13300 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2018-08-27 | 2018-11-26 | 59284 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2021-07-09 | 2021-09-27 | 142269 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2017-05-10 | 2017-07-19 | 9849 |
| APO-ALENDRONATE | 70MG | TABLET | Resolved | 2019-06-12 | 2019-07-12 | 86271 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |